Published in Clin Exp Immunol on December 01, 2001
Human primary gastric dendritic cells induce a Th1 response to H. pylori. Mucosal Immunol (2010) 1.10
Role of bacteria in oncogenesis. Clin Microbiol Rev (2010) 1.05
CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting. World J Gastroenterol (2014) 1.02
Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun (2003) 1.02
CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med (2007) 0.99
Concepts of oxidative stress and antioxidant defense in Crohn's disease. World J Gastroenterol (2013) 0.90
Native and bone marrow-derived cell mosaicism in gastric carcinoma in H. pylori-infected p27-deficient mice. Oncotarget (2016) 0.84
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. Cancer Lett (2014) 0.83
Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med (2007) 0.82
Synergistic up-regulation of CXCL10 by virus and IFN γ in human airway epithelial cells. PLoS One (2014) 0.77
Activation of c-Jun N-terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats. Clin Exp Immunol (2006) 0.76
Lower circulating levels of chemokine CXCL10 in Helicobacter pylori-infected patients with peptic ulcer: Influence of the bacterial virulence factor CagA. Iran J Microbiol (2013) 0.75
CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata. J Immunol (2016) 0.75
PRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ Costimulation. PLoS One (2016) 0.75
Organization and promoter analysis of the zebrafish (Danio rerio) chemokine gene (CXC-64) promoter. Fish Physiol Biochem (2009) 0.75
Human chemokines: an update. Annu Rev Immunol (1997) 8.43
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest (1998) 6.51
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A (1996) 5.26
Lymphocyte traffic control by chemokines. Nat Immunol (2001) 4.86
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12
The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol (1999) 2.99
Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology (1995) 2.48
Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology (1997) 2.37
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest (1999) 2.16
Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem (1997) 2.05
Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol (1994) 2.04
Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology (2001) 1.86
The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol (1995) 1.83
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol (1999) 1.62
Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun (1997) 1.52
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Helicobacter pylori and gastric inflammation. Br Med Bull (1998) 1.49
Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol (1993) 1.41
Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol (1999) 1.40
Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect Immun (1997) 1.38
Interleukin 8: cells of origin in inflammatory bowel disease. Gut (1996) 1.35
Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am J Gastroenterol (1996) 1.28
Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig Dis Sci (1998) 1.27
A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. Gastroenterology (2000) 1.26
CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. Clin Exp Immunol (2000) 1.25
Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol (2000) 1.17
Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease. Scand J Gastroenterol (1993) 1.13
Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori. Infect Immun (1996) 1.08
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine (1999) 1.00
Chemokines, lymphocytes and viruses: what goes around, comes around. Curr Opin Immunol (1998) 0.97
Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun (2000) 0.95
The immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis (1997) 0.95
Immune suppressive effects of Helicobacter pylori on human peripheral blood mononuclear cells. Med Microbiol Immunol (1993) 0.95
C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur J Immunol (1999) 0.92
Helicobacter pylori gastritis: a Th1 mediated disease? J Biotechnol (2000) 0.88
Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest (2000) 3.47
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology (2001) 2.69
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut (2003) 2.39
Complications of double balloon enteroscopy: a multicenter survey. Endoscopy (2007) 2.28
Gastric inhibitory action of H2-antagonists ranitidine and cimetidine. Lancet (1979) 2.01
Carbon dioxide insufflation improves intubation depth in double-balloon enteroscopy: a randomized, controlled, double-blind trial. Endoscopy (2007) 1.98
Spontaneous flow of bile through the human pancreatic duct in the absence of pancreatitis: nature's human experiment. Endoscopy (2003) 1.95
Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine. Gastroenterology (1980) 1.93
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol (2001) 1.67
Single- vs. double-balloon enteroscopy in small-bowel diagnostics: a randomized multicenter trial. Endoscopy (2011) 1.59
Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion (2002) 1.51
Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Endoscopy (1999) 1.51
Gastrointestinal miniprobe sonography: the current status. Am J Gastroenterol (2000) 1.44
Mechanical lithotripsy of bile duct stones in 209 patients--effect of technical advances. Endoscopy (1988) 1.39
Cholangiofibromatosis associated with portal hypertension. Am J Gastroenterol (1994) 1.39
Effects of 13-nle-motilin in man--inhibition of gastric evacuation and stimulation of pepsin secretion. Scand J Gastroenterol (1975) 1.35
Preoperative diagnosis of bile duct strictures--comparison of intraductal ultrasonography with conventional endosonography. Scand J Gastroenterol (2000) 1.31
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. Dtsch Med Wochenschr (1985) 1.31
New histamine H2-receptor antagonists. Hepatogastroenterology (1980) 1.30
Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol (1995) 1.30
Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion (1995) 1.25
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology (1998) 1.20
Plasma secretin and pancreatic bicarbonate response to exogenous secretin in man. Gut (1977) 1.19
Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology (2001) 1.19
Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut (2004) 1.17
Motilin-induced electrical activity in the canine gastrointestinal tract. Scand J Gastroenterol Suppl (1976) 1.15
Tumors of the papilla of Vater--inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy. Ann Oncol (1999) 1.15
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. J Physiol Pharmacol (1997) 1.15
Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Clin Exp Immunol (2001) 1.14
Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects. Gut (1994) 1.13
Analysis of the motor effects of 13-norleucine motilin on the rabbit, guinea pig, rat, and human alimentary tract in vitro. Gastroenterology (1975) 1.11
Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma. J Natl Cancer Inst (1999) 1.11
[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011]. Z Gastroenterol (2011) 1.11
Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol (1997) 1.10
Release of motilin after duodenal acidification. Lancet (1976) 1.10
Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy (2002) 1.10
Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Gut (1978) 1.09
[Piezoelectric lithotripsy of gallstones. Initial clinical experiences]. Dtsch Med Wochenschr (1988) 1.08
Exocrine pancreatic function in juvenile diabetics. Am J Dig Dis (1975) 1.08
Gastric duplication cyst: a rare endosonographic finding in an adult. Scand J Gastroenterol (2005) 1.08
Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT--a prospective, histopathologically controlled study. Gastrointest Endosc (1999) 1.07
Tissue reactions under piezoelectric shockwave application for the fragmentation of biliary calculi. Gut (1989) 1.06
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.06
Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut (2006) 1.06
Bicarbonate and cyclic AMP content of pure human pancreatic juice in response to graded doses of synthetic secretin. Gastroenterology (1976) 1.05
CD98-mediated links between amino acid transport and beta 1 integrin distribution in polarized columnar epithelia. J Biol Chem (2001) 1.05
Cogan's syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol (2001) 1.05
Pharmacokinetics of motilin in man. Gastroenterology (1977) 1.03
The myeloic related protein MRP8/14 (27E10 antigen)--usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest (1995) 1.03
Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin Exp Immunol (1996) 1.02
Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3. Scand J Rheumatol (2005) 1.02
Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study. Gut (2002) 1.02
Role of M cells in intestinal barrier function. Ann N Y Acad Sci (2000) 1.01
Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease. Clin Exp Immunol (2010) 1.00
Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta. J Immunol (1999) 0.99
IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol (1998) 0.99
Biliary stent occlusion--a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy (1992) 0.99
Effect of 13-Nle-motilin on small intestinal transit time in healthy subjects. Scand J Gastroenterol Suppl (1976) 0.98
Standardized grey scale ultrasonography in Graves' disease: correlation to autoimmune activity. Eur J Endocrinol (1999) 0.98
CCR6 identifies lymphoid tissue inducer cells within cryptopatches. Clin Exp Immunol (2010) 0.98
Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther (2001) 0.97
Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. Hoppe Seylers Z Physiol Chem (1971) 0.96
Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Scand J Gastroenterol (1994) 0.96
Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J Gastroenterol (2006) 0.96
Influence of enkephalin on K+-evoked efflux of putative neurotransmitters in rat brain. Selective inhibition of acetylcholine and dopamine release. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.96
SPINK1 mutations and phenotypic expression in patients with pancreatitis associated with trypsinogen mutations. J Med Genet (2003) 0.95
Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology (Oxford) (2001) 0.94
Decrease in plasma amino acid level after secretin and pancreozymin as an indicator of exocrine pancreatic function. Gastroenterology (1986) 0.94
Piezoelectric lithotripsy of gallstones. Lancet (1987) 0.94
Common bile duct obstruction due to candidiasis. Scand J Gastroenterol (2001) 0.94
Long-term experience in Wallstent therapy for malignant choledochal stenosis. Endoscopy (1994) 0.94
Some properties of mucus in patients with gastric ulcer. Effect of treatment with carbenoxolone sodium. Scand J Gastroenterol (1972) 0.94
The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility. Scand J Gastroenterol (1994) 0.93
Partial purification of hog kidney sodium-D-glucose cotransport system by affinity chromatography on a phlorizin polymer. Biochim Biophys Acta (1981) 0.93
Release of VIP, secretin and motilin after duodenal acidification in man. Acta Hepatogastroenterol (Stuttg) (1978) 0.93
Epithelial cell turnover and mucus production in man. Adv Exp Med Biol (1977) 0.93
Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study. Gut (1990) 0.92
Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis. Exp Clin Endocrinol Diabetes (2005) 0.92
Gastric mucosal histamine in duodenal-ulcer patients: release by secretin. Acta Hepatogastroenterol (Stuttg) (1977) 0.92
NMR spectrometry. A new method for total stool fat quantification in chronic pancreatitis. Dig Dis Sci (1987) 0.92
CD4+ Th1-cells predominate in low-grade B-cell lymphoma of gastric mucosa-associated lymphoid tissue (MALT type). Scand J Gastroenterol (2001) 0.92
Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis. Int J Pancreatol (1993) 0.91
Colon capsule endoscopy versus standard colonoscopy in assessing disease activity of ulcerative colitis: a prospective trial. Tech Coloproctol (2013) 0.91
Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut (1995) 0.91
Colitis as the initial presentation of Wegener's granulomatosis. J Intern Med (1997) 0.90
Immunohistochemical localization of motilin in endocrine non-enterochromaffin cells of the small intestine of humans and monkey. Gastroenterology (1979) 0.90
Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis. Hepatogastroenterology (1985) 0.90